Drug Profile
Influenza A virus vaccine H1N1 - Fluart Innovative Vaccines
Alternative Names: FLUVAL P H1N1; Influenza virus vaccine H1N1 monovalent - Fluart Innovative VaccinesLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Omninvest
- Developer Fluart Innovative Vaccines
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza A virus H1N1 subtype
Most Recent Events
- 01 Jan 2010 Launched for Influenza-A virus H1N1 subtype (prevention in children, adolescents and elderly) in Hungary (IM)
- 06 Oct 2009 Registered for Influenza-A virus H1N1 subtype (in children aged 1-3 years) in Hungary (IM)
- 06 Oct 2009 Registered for Influenza-A virus H1N1 subtype (prevention in children and adolescents aged 3-18 years) in Hungary (IM)